90 related articles for article (PubMed ID: 7968725)
1. Angiotensin converting enzyme inhibitors and diabetic renal disease. ACE inhibitors may prevent progression from incipient to clinical nephropathy.
Gilbert RE; Jerums G
Med J Aust; 1994 Nov; 161(10):583-4. PubMed ID: 7968725
[No Abstract] [Full Text] [Related]
2. An evidence-based review of ACE inhibitors in incipient diabetic nephropathy.
Haider A; Oh P; Peloso PM
Can J Clin Pharmacol; 2000; 7(2):115-9. PubMed ID: 10958708
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
5. Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria?
Sferra L; Kelsberg G; Dodson S; Saseen J
J Fam Pract; 2004 Jan; 53(1):68-9. PubMed ID: 14709273
[No Abstract] [Full Text] [Related]
6. ACE inhibitors as a shield against diabetic nephropathy.
Materson BJ
Arch Intern Med; 1996 Feb; 156(3):239-40. PubMed ID: 8572832
[No Abstract] [Full Text] [Related]
7. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Cantarovich F; Rangoonwala B
Int J Clin Pract; 2003 Nov; 57(9):801-22. PubMed ID: 14686572
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.
Elliott HL
Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843
[TBL] [Abstract][Full Text] [Related]
9. [Renal protection in the diabetic patient with ACE inhibitors].
Pérez Blanco FJ; Rodríguez Cuartero A
Rev Clin Esp; 1992 Nov; 191(7):393-4. PubMed ID: 1475469
[No Abstract] [Full Text] [Related]
10. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists].
Tesar V
Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169
[TBL] [Abstract][Full Text] [Related]
11. To prevent progression: ACE inhibitors, calcium antagonists or both?
Stefanski A; Amann K; Ritz E
Nephrol Dial Transplant; 1995; 10(2):151-3. PubMed ID: 7753444
[No Abstract] [Full Text] [Related]
12. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.
Clark WF; Churchill DN; Forwell L; Macdonald G; Foster S
CMAJ; 2000 Jan; 162(2):195-8. PubMed ID: 10674051
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of diabetic nephropathy. Effects of ACE inhibition on microcirculation].
Haak T; Haak E; Jungmann E; Kusterer K; Usadel KH
Fortschr Med; 1997 Dec; 115(35-36):26-9. PubMed ID: 9499637
[TBL] [Abstract][Full Text] [Related]
14. [Renal protection in diabetic patients with ACE inhibitors].
González Alvarez MT
Rev Clin Esp; 1991 Nov; 189(8):351-3. PubMed ID: 1784795
[No Abstract] [Full Text] [Related]
15. [Diabetic nephropathy].
Metsärinne K
Duodecim; 2003; 119(24):2445-50. PubMed ID: 14870506
[No Abstract] [Full Text] [Related]
16. ACE inhibitor slows onset of renal disease in diabetics by 50%.
Lefton CK
Nephrol News Issues; 1993 Dec; 7(12):8, 11. PubMed ID: 8264813
[No Abstract] [Full Text] [Related]
17. ACE-I and ARBs in early diabetic nephropathy.
Mauer M; Zinman B; Gardiner R; Drummond KN; Suissa S; Donnelly SM; Strand TD; Kramer MS; Klein R; Sinaiko AR
J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):262-9. PubMed ID: 12584670
[TBL] [Abstract][Full Text] [Related]
18. [Diabetic nephropathy--methods of preventing and inhibiting progression].
Klinger M
Przegl Lek; 1995; 52(4):138-40. PubMed ID: 7638360
[No Abstract] [Full Text] [Related]
19. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
Luño J; Valderrábano F
An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
[No Abstract] [Full Text] [Related]
20. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
Viberti G; Chaturvedi N
Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
